Cartalax is a peptide made of three amino acids: alanine, glutamic acid and aspartic acid. It comes from the same short-peptide bioregulator research as Pinealon and Epithalon. It is studied in cartilage and connective-tissue models. Peptides this short are studied for direct interaction with DNA rather than for binding a receptor. That is an unusual mechanism.
The numbers that define Cartalax and how it is being studied. For laboratory research use only.
3
Amino Acids
Ala-Glu-Asp (AED) tripeptide
AED
Sequence Code
One-letter code for Ala-Glu-Asp
4
Research Areas
Cartilage & Chondrocyte Models
Peptide-Gene Expression
Cellular Aging
How It Works
How Cartalax works
The pathways Cartalax acts on - and what each one does. The animation traces its signal outward from the compound to every target it engages.
Signalling pathways studied in preclinical models · illustrative
Gene-Level Bioregulation
Peptide-DNA Interaction
Cartalax is a short tripeptide (Ala-Glu-Asp). Research from the Khavinson group proposes that peptides of this class interact with chromatin and the promoter regions of specific genes, influencing transcription of tissue-specific proteins.
Proposed binding to promoter regions of specific genes
Associated with sequence-specific changes in gene expression
Studied as an epigenetic-level regulator rather than a receptor agonist
Cartilage & Chondrocyte Focus
Connective Tissue
AED is studied as a bioregulator for cartilage and connective tissue. Cell-culture research has examined its effect on chondrocytes and fibroblasts, with proliferation and extracellular-matrix markers as measured endpoints.
Studied in chondrocyte and fibroblast cultures
Extracellular-matrix markers measured
Proliferation endpoints measured
Aging Cell-Culture Models
Cellular Aging
Short-peptide bioregulators are investigated in models of cellular aging. For AED, studies have examined markers of proliferation and apoptosis in aging connective-tissue cell cultures.
Studied in aging cell-culture models
Apoptosis markers measured
Investigated alongside other short-peptide bioregulators
Uses & Applications
What Cartalax is researched for
The main areas Cartalax is being studied for - and the study-reported figures behind them.
CONNECTIVE TISSUE
Cartilage & Chondrocyte Models
AED is studied as a cartilage-associated bioregulator, with chondrocyte proliferation and matrix markers as measured endpoints in cell-culture research.
MOLECULAR BIOLOGY
Peptide-Gene Expression
Short peptides of this class are studied as regulators of gene expression and protein synthesis, with proposed binding to specific DNA promoter regions.
GERONTOLOGY
Cellular Aging Models
AED is investigated in aging cell-culture models, measuring proliferation and apoptosis markers in connective-tissue cells.
MUSCULOSKELETAL
Musculoskeletal Tissue Research
Cartalax is studied alongside other short-peptide bioregulators in research on joint and connective-tissue biology.
Study-reported magnitudes
Representative figures from published research. Bars fill as you scroll.
Cell Proliferation (aging culture models)Measured
Apoptosis MarkersMeasured
Extracellular-Matrix Protein ExpressionMeasured
Cell ViabilityMeasured
Figures are representative of published research findings and shown for reference.
Molecular Structure
The Cartalax molecule
An interactive 3D model rendered from the compound record - rotate and explore its structure.
Cartalax is a synthetic tripeptide, Ala-Glu-Asp (AED), from the short-peptide bioregulator research of the Khavinson group. It is studied in cartilage and connective-tissue models.
All three are short-peptide bioregulators from the same line of research. Pinealon (EDR) is studied in neuronal models, Epithalon (AEDG) in pineal and telomere research, and Cartalax (AED) in cartilage and connective-tissue models.
Cartalax has a molecular weight of 333.29 g/mol. Every vial is supplied at ≥99% purity, verified by HPLC, with a Certificate of Analysis included.
Store lyophilized vials at -20°C for long-term stability, protected from light and moisture.
No. Cartalax is sold strictly as a research compound for laboratory and in-vitro use only. It is not intended for human or animal consumption, diagnosis, or treatment.
Research Use Only.
Not for human or veterinary use. For in-vitro laboratory research only. These statements have not been evaluated by the FDA; this product is not intended to diagnose, treat, cure, or prevent any disease. Sold exclusively to qualified researchers and institutions.
